Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Endothelial Dysfunction
100%
Mesenchymal Stem Cells
100%
Intratracheal
100%
Monocrotaline
100%
Monocrotaline-induced Pulmonary Hypertension
100%
Acetylcholine
42%
Pulmonary Artery Pressure
28%
Pulmonary Vascular Resistance
28%
Lung Parenchyma
28%
Lung
14%
Intravenous Injection
14%
Airway
14%
Sodium Nitroprusside
14%
Pulmonary Artery
14%
Pulmonary Vascular
14%
Right Ventricular Hypertrophy
14%
Von Willebrand Factor
14%
Widespread Distribution
14%
LacZ
14%
Vascular Resistance
14%
Immunofluorescence Study
14%
Pressure Resistance
14%
Immunohistochemical Study
14%
Pulmonary Response
14%
Systemic Response
14%
Paracrine Effect
14%
α-smooth muscle Actin (α-SMA)
14%
Intratracheal Injection
14%
Endothelium-dependent
14%
Endothelium-dependent Vasodilation
14%
Smooth muscle Phenotype
14%
Intratracheal Administration
14%
Pulmonary Vascular Response
14%
Vascular Endothelial Function
14%
Rat Mesenchymal Stem Cells
14%
Vasodilator Agents
14%
Pulmonary Hypertension Treatment
14%
Pharmacology, Toxicology and Pharmaceutical Science
Monocrotaline-Induced Pulmonary Hypertension
100%
Endothelial Dysfunction
100%
Rat
100%
Monocrotaline
63%
Acetylcholine
27%
Vasodilator Agent
9%
Nitroprusside Sodium
9%
Smooth Muscle Actin
9%
Heart Right Ventricle Hypertrophy
9%
Pulmonary Hypertension
9%
Von Willebrand Factor
9%